Dr. Jonathan Wingfield

AstraZeneca

AstraZeneca Optimizes Ultra High-Throughput Drug Discovery Screening using Acoustic Liquid Handling Technology

Steve Rees, VP of screening sciences and sample management at AstraZeneca, discusses how combing acoustic liquid handling and mass spectrometry can increase throughput of samples and decrease assay development costs by up to 1000-fold. Find out how AstraZeneca’s partnership with Labcyte will impact metabolomics and drug discovery screening.



LIKE 3
Dr. Jonathan Wingfield
SLAS2020 ELRIG Screening

Dr. Jonathan Wingfield

Biography

Principal Scientist, Screening Sciences and Sample Management Function Discovery Sciences, AstraZeneca More
Follow Jonathan

Dr. Jonathan Wingfield

AstraZeneca

Dr. Jonathan Wingfield  is a Principal Scientist within the Screening Sciences and Sample Management function Discovery Sciences at AstraZeneca. He provides scientific leadership to his team, focusing on addressing the key questions facing early drug discovery through high quality science and innovative application of technology. His team work on projects on high-throughput mass spectrometry and intracellular surface-enhanced Raman spectroscopy in the investigation of nanomaterial interactions and the understanding of biochemical pathways and pharmacodynamics.